# insitro: Information technology & services, South San Francisco, United States > insitro: insitro is a biotechnology research firm based in South San Francisco, California, founded in 2018 by AI pioneer Daphne Koller. Source: https://millionrounds.com/startup/insitro (Millionrounds; every figure on the page links to its filing or article) United States · [Information technology & services startup](https://millionrounds.com/companies) # insitro insitro is a biotechnology research firm based in South San Francisco, California, founded in 2018 by AI pioneer Daphne Koller. Funding reported Last round: Series C Information technology & services South San Francisco, United States Company summary - **Founded:** 2018 8 years old - **Team:** 260 201 to 1,000 people - **Funding reported:** $643M in dollars - **Last round:** Series C Mar 2021 How sure we are - ✓ **Listed** We know it exists and what it does - 2 **Funding reported** A company dataset reports a raise - 3 **Observed** A filing or a dated announcement confirms a round No round for insitro has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology) ## About insitro insitro is a biotechnology research firm based in South San Francisco, California, founded in 2018 by AI pioneer Daphne Koller. The company focuses on machine learning and data-driven approaches to drug discovery and development, aiming to create better medicines more efficiently. With around 300 employees, insitro is dedicated to addressing the challenges of drug development by predicting clinical outcomes earlier through its innovative technologies. The company offers drug discovery services and platform licensing to pharmaceutical partners, utilizing its proprietary AI ecosystem. Key technological assets include the Virtual HumanTM AI engine, which analyzes vast datasets to understand disease mechanisms, and the TherMLTM AI Platform, designed to identify genetic drivers for optimal medicine design. Insitro collaborates with major pharmaceutical companies like Bristol Myers Squibb, Eli Lilly, and Gilead, generating revenue through partnerships and platform licensing. The company is advancing a pipeline of therapeutics focused on neuroscience and metabolic diseases, leveraging its advanced data capabilities to enhance drug development processes. ## What company datasets say insitro raised Funding, as reported Reported in all **$643M** in dollars Rounds **3** Last round **Series C** Last round size **$400M** Last round date **Mar 2021** Investors listed **19** Valuation **$2.4B, Mar 2026** SEC Form D **$143M sold, 1 filing, last May 2020** ## Founders and team From insitro's own website and the SEC filings it signed: 50 on the team. - **Daphne Koller** Chief Executive Officer i - **Mary Rozenman** Chief Financial Officer i - **Dave Light** VP, Strategy & Corporate Development - **Adam Altrichter** Associate Director, Strategy & Business Development - **Ahmed Sandakli** Manager - **Alice Chin** Senior Software Engineer - **Andrew Balthrope** Lead Lab Operations Assistant - **Anthony Ha** Associate Scientist II - **Ariel Kauss** Senior Scientist - **Audrey Musselman-Brown** Senior Manager, SW Engineering - **Babacar Ndoye** Manager, Research Ops - **Bay Johnson** Associate Scientist II - **Casey Chance** Staff Software Engineer - **Chinmayi Kashyap** Associate Scientist II - **Chris Baker** Director, Research Operations - **Christoph Klein** Senior Director, Software Engineering - **Derek Hollingsworth** Associate Scientist III - **Difei Xu** Associate Scientist III And 32 more on the team. On the board, as filed i *Robert Nelsen* *Vijay Pande* ## On 4 portfolio pages Investors who name them - [Bezos Expeditions](https://millionrounds.com/fund/bezos-expeditions) - [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) - [AGI Alliance](https://millionrounds.com/fund/agi-alliance) - [Rona Holdings](https://millionrounds.com/fund/rona-holdings) Each firm lists insitro on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source. ## The company, in detail What they build Known for health care metabolism disease pathways innovative drug delivery customer engagement digital biomarkers biological data resources biotechnology research clinical data analysis genomic data data science biotech data infrastructure metabolic diseases genetics and biology enterprises neurodegenerative diseases Built with from their website Resi Amazon SES Google Tag Manager Canva ANS WordPress.org Ironclad Atlassian LipScore Flow +8 more Modula Google Workspace CloudFlare Gem Viewport Meta CookieYes Element UI CloudSponge - **Sector:** Information technology & services - **Industry code:** NAICS 541714, SIC 2834 - **Region:** California - **Revenue:** $69M a year, as listed - **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/insitro) ## Information technology & services in United States Startups like it - [**Databricks** San Francisco · founded 2013 *Raised*](https://millionrounds.com/company/databricks) - [**Waymo** Mountain View · founded 2009 *Raised*](https://millionrounds.com/company/waymo) - [**Crusoe** Denver · founded 2018 *Raised*](https://millionrounds.com/company/crusoe) - [**Cursor** San Francisco · founded 2017 *Raised*](https://millionrounds.com/company/cursor) - [**Thinking Machines Lab** San Francisco *Raised*](https://millionrounds.com/company/thinking-machines-lab) - [**Cognition** San Francisco *Raised*](https://millionrounds.com/company/cognition) - [**Polymarket** New York · founded 2020 *Raised*](https://millionrounds.com/company/polymarket) - [**Harvey** San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/harvey) ## Is this your company? Add your raise, your deck and your story, and put insitro in front of investors. Or tell us what we have wrong. [List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)